HYBRIGENICS (EPA:ALHYG) | WebDisclosure

Basculer en Français

10161	Companies
208730	Keywords
138855	Articles
110646	Press releases

Home
Companies
HYBRIGENICS

BRIEF

published on 04/01/2026 at 18:05, 2 days 3 hours ago

Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals

Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF

published on 04/01/2026 at 18:05, 2 days 3 hours ago

Groupe Aton : Vers une Réduction des Échecs Cliniques en Pharmaceutique

R&D Essais Cliniques Pharmaceutique Groupe Aton Prédictivité
PRESS RELEASE

published on 04/01/2026 at 18:00, 2 days 3 hours ago

AMÉLIORER LE TAUX DE SUCCÈS DES ESSAIS CLINIQUES : UN ENJEU STRUCTURANT POUR LA RetD PHARMACEUTIQUE AU COEUR DE LA STRATÉGIE DU GROUPE ATON
Le Groupe Aton se concentre sur l'avant-clinique intelligent pour améliorer la prédictivité des décisions en R&D pharmaceutique et réduire le risque clinique. Prochaine publication sur Bcell Design et résultats annuels le 28 avril 2026

R&D Pharmaceutique Aton Avant-clinique Intelligent Risque Clinique Bcell Design
BRIEF

published on 03/11/2026 at 18:35, 23 days 2 hours ago

Inoviem Scientific Advances Drug Development with Patient-Centric Approach

Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
BRIEF

published on 03/11/2026 at 18:35, 23 days 2 hours ago

Inoviem Scientific Advances Développement de médicaments avec une approche centrée sur le patient

Médecine Personnalisée Innovation Pharmaceutique Inoviem Scientifique Développement De Médicaments Centré Sur Le Patient Programmes Précliniques
PRESS RELEASE

published on 03/11/2026 at 18:30, 23 days 2 hours ago

ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC
Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data

AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF

published on 03/11/2026 at 18:20, 23 days 2 hours ago

Inoviem Scientific : Avancées dans le Développement Pharmaceutique

Médecine Personnalisée Développement Pharmaceutique Pharmacologie Translationnelle Inoviem Scientific Plateforme Intégrée
BRIEF

published on 03/11/2026 at 18:20, 23 days 2 hours ago

Inoviem Scientific: Advances in Pharmaceutical Development

Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
PRESS RELEASE

published on 03/11/2026 at 18:15, 23 days 2 hours ago

ATON : POINT D'AVANCEMENT SUR L'ACTIVITÉ DE LA FILIALE INOVIEM SCIENTIFIC
Le Groupe Aton via sa filiale Inoviem Scientific innove dans le développement de médicaments en utilisant des échantillons de patients pour des analyses moléculaires assistées par IA

Médecine Personnalisée Développement Pharmaceutique Groupe Aton Innovation Thérapeutique Inoviem Scientific
BRIEF

published on 02/18/2026 at 18:35, 1 month 13 days ago

Hadrien Lanvin appointed Deputy Managing Director of the Aton Group

Biotechnology Life Sciences Appointment Hadrien Lanvin Aton Group

1 2 ... 6

Accesswire

Published on 04/02/2026 at 22:00, 23 hours 9 minutes ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 2 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 6 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 6 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 6 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/03/2026 at 18:00, 3 hours 8 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 3 hours 8 minutes ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 3 hours 23 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:40, 3 hours 29 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.04.26.
Published on 04/03/2026 at 17:05, 4 hours 3 minutes ago

At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence

Les Echos

Published on 04/03/2026 at 18:46, 2 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 hours 22 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 3 hours 7 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 3 hours 8 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 3 hours 9 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE